CD70 and head and neck squamous cell carcinoma: utilized a retroviral human CD70 CAR construct to generate CD70 CAR-T and found that it presented the capacity of efficiently eliminating CD70-positive HNSCC cells, which might be related to the transduction efficiency, the CD4+/CD8+ T cell ratio, and a different response to IL-2 stimulation.